IBM ILOG helps new IT target drug counterfeiting in developing countries
May 17, 2012 No CommentsSproxil, a startup that develops tools for brand protection in emerging markets, has enlisted IBM technology to help reduce drug counterfeiting and help consumers to verify the authenticity of prescriptions with their smartphones. Through its collaboration with IBM, Sproxil officials say the company is extending manufacturers’ ability to view and analyze real time consumer data to detect and prevent drug counterfeiting in developing countries – where 25 to 50 percent of medicines are believed to be counterfeit, costing the pharmaceutical industry as much as $75 billion a year.

Inside the Briefcase






